USPTO serial 79134609
DIAXONHIT SPECIALTY DIAGNOSTIC SOLUTIONS
Reviewed by CopyMark Law Group
Reg. 4553916Status 404
- Filing date
- Status date
- Registration date
- Jun 24, 2014
- Examiner
- BUNCH, TASHIA AUNGELIK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DIAXONHIT SPECIALTY DIAGNOSTIC SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-75013 PARIS, FR
F-75013 PARIS, FR
F-75013 PARIS, FR
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical and biological reagents for medical use for diagnostics, namely, chemical and biological reagents for use in tests based on blood or biological biomarkers enabling the identification of patients affected by diseases or being at risk of developing a disease and for enabling the identification of patients responding to specific personalized medical treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; biopharmaceutical products for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical preparations for medical, pharmaceutical or veterinary purposes, especially chemical preparations for diagnosing diseases and in particular infectious diseases, neurodegenerative diseases and cancers; medical and clinical diagnostic products, namely, beads, microspheres, nucleic acid or antigen banks, nucleic acids, antigens on beads, or on microspheres, on biochips or on other media; DNA libraries, RNA libraries and antigen libraries, namely, biological materials in the nature of tissue and samples of blood for medical diagnosis and companion diagnosis for medical purposes; nucleic acid or antigen sequences, namely, biological materials intended for medical use and medical diagnosis, namely, for decoding the genes and proteins affected by diseases or revealing the transcriptomic signature of patients affected by diseases and for the detection of specific antibodies produced by patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; chemical reagents for medical use contained in diagnostic testing kits for collecting biological samples required for the preservation of the biological material under analysis to carry out the test in appropriate conditions | SECTION 71 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, especially apparatus and instruments, namely, fluorescent instruments in the nature of fluorescent tracers and fluorescent dye and fluorescence microscope and X-ray fluorescence spectrometer used for identifying diseases, assessing the severity of these diseases, assessing prognoses of these diseases, measuring the progression of a disease; medical devices using beads, microspheres and fluorescent instruments, and biopsies for analyzing blood or other biological materials; apparatus for medical use for analyzing blood or other products of the human body; apparatus for medical diagnosis, namely, kits for taking samples of blood or other products of the human body comprising medical instruments for taking blood, DNA collection for diagnosing diseases, and materials required for the preservation of any product of the human body under analysis to carry out the test under good conditions; spoons for administering medicine; containers specially adapted to the application of medicines, namely, small bags and pouches used for administering medicines; probes for medical use; syringes for medical use; galvanic therapeutic appliances particularly for diagnosing diseases; probes and kits comprised of materials and medical instruments for taking blood samples, for collecting DNA and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers for medical and clinical diagnosis | SECTION 71 - CANCELLED | — |
| 042 | Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analysis; chemical research; chemistry services, namely, analysis of RNA genes, antigens, tissue and samples of blood or other biological materials; biotechnological project studies for identifying people suffering from diseases and to measure the severity of these diseases, the prognoses, progression and conversion of the disease and to determine the responsiveness of patients to treatments, especially personalized medical treatments; research and development of new products for others;biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analysis, namely, quantification of nucleic acid content intended for medical and scientific research | SECTION 71 - CANCELLED | — |
| 044 | Medical services; veterinary services; medical assistance; consultancy in the field of biotechnology and pharmacy, namely, to assist in the selection of people suffering from diseases for clinical trials and to offer targeted care and personalized medical solutions; hospital services; services for the pharmaceutical industry and pharmacists, those who prepare prescriptions, namely, immunology, infectiology, cancerology, geriatric and neurological services, in order to facilitate diagnoses and undertaking therapy; health care services; telemedicine services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DIAXONHIT
- Other trademarks owned by DIAXONHIT
- Other trademarks owned by DIAXONHIT
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DIAXONHIT SPECIALTY DIAGNOSTIC SOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 22, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Oct 22, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 3, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 27, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 26, 2022 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Jan 23, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 9, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 9, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 24, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 24, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 8, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 4, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 19, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 19, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 19, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 2, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 24, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 6, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jan 24, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 4, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 4, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 1, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 31, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 23, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |